Comments on the Retraction by PLoS ONE of a Laboratory Study on Arnica montana

Area of Science:

• Immunology
• Molecular Biology
• Homeopathic Medicine

Background:

• A 2016 study in PLoS ONE reported effects of homeopathic *Arnica montana* on macrophages.
• The research focused on interleukin-4 treated human macrophages and extracellular matrix gene expression.
• Specifically, it noted an increase in fibronectin gene expression, crucial for connective tissue healing.

Purpose of the Study:

• To address the retraction of a 2016 research article on homeopathic *Arnica montana*.
• To critically analyze the methodological points raised in the retraction note.
• To discuss the implications for research on high dilutions of natural compounds.

Main Methods:

• Review of the original research article and the subsequent retraction note.
• Focus on specific methodological aspects concerning high dilutions.
• Analysis of scientific conventions regarding study replication and discussion of results.

Main Results:

• The authors argue that the retraction note did not substantiate methodological errors or scientific misconduct.
• The original findings indicated increased extracellular matrix gene expression, including fibronectin.
• The retraction is presented as a deviation from standard scientific discourse and knowledge-sharing practices.

Conclusions:

• The retraction of the *Arnica montana* study by PLoS ONE is contested.
• The authors assert that the retraction violates established scientific publication and knowledge-sharing conventions.
• The discussion highlights the importance of replication and open scientific debate over retraction based on perceived scientific conflict.